Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
November 03, 2026 13.60
November 02, 2026 13.06
October 30, 2026 13.44
October 29, 2026 13.35
October 28, 2026 13.07
October 27, 2026 13.18
October 26, 2026 12.61
October 23, 2026 12.67
October 22, 2026 13.30
October 21, 2026 13.52
October 20, 2026 13.40
October 19, 2026 12.73
October 16, 2026 12.27
October 15, 2026 12.88
October 14, 2026 12.59
October 13, 2026 12.50
October 12, 2026 12.80
October 09, 2026 13.10
October 08, 2026 12.67
October 07, 2026 12.77
October 06, 2026 13.06
October 05, 2026 12.94
October 02, 2026 12.94
October 01, 2026 13.08
September 30, 2026 13.55
Date Value
September 29, 2026 13.63
September 28, 2026 13.90
September 25, 2026 13.73
September 24, 2026 14.03
September 23, 2026 14.25
September 22, 2026 15.37
September 21, 2026 15.08
September 18, 2026 15.09
September 17, 2026 15.80
September 16, 2026 15.19
September 15, 2026 15.44
September 14, 2026 15.66
September 11, 2026 14.72
September 10, 2026 14.94
September 09, 2026 15.09
September 08, 2026 15.78
September 04, 2026 15.88
September 03, 2026 15.81
September 02, 2026 16.06
September 01, 2026 15.74
August 31, 2026 15.72
August 28, 2026 16.18
August 27, 2026 17.31
August 26, 2026 17.27
August 25, 2026 17.44

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Pfizer Inc. 2.052
Eli Lilly & Co. 33.30
Merck & Co., Inc. 8.749
Bristol Myers Squibb Co. 5.525
ANI Pharmaceuticals, Inc. 2.776

Price to Book Value Related Metrics

Price 28.91
Earnings Yield -4.96%
Market Cap 3.220B